Zide and Hypoproteinaemia - a phase IV clinical study of FDA data

Summary:

Hypoproteinaemia is reported as a side effect among people who take Zide (hydrochlorothiazide), especially for people who are female, 60+ old, also take Rezulin, and have Oedema peripheral.

The phase IV clinical study analyzes which people have Hypoproteinaemia when taking Zide. It is created by eHealthMe based on reports of 178,473 people who have side effects when taking Zide from the FDA, and is updated regularly.

What is Zide?

Zide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 183,246 Zide users. Check the latest studies of Zide.

What is Hypoproteinaemia?

Hypoproteinaemia (too little prolactin circulating in the blood) is found to be associated with 533 drugs and 563 conditions by eHealthMe. Check the latest studies of Hypoproteinaemia.

On Jul, 19, 2026

178,473 people reported to have side effects when taking Zide.
Among them, 32 people (0.02%) have Hypoproteinaemia.

Among these 32 people:

What is the gender of people who have Hypoproteinaemia when taking Zide? *

female: 59.38 %
male: 40.62 %

What is the age of people who have Hypoproteinaemia when taking Zide? *

What are other drugs people take besides Zide? *

What are other side effects people have besides Hypoproteinaemia? *

Weakness: 12 people, 37.50%
Acute Kidney Failure: 11 people, 34.38%
Hypokalemia (low potassium): 10 people, 31.25%
Oedema Peripheral (superficial swelling): 9 people, 28.12%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 8 people, 25.00%
Dehydration (dryness resulting from the removal of water): 7 people, 21.88%
Ascites (accumulation of fluid in the abdominal cavity): 7 people, 21.88%
Weight Decreased: 7 people, 21.88%
Hypotension (abnormally low blood pressure): 7 people, 21.88%
Nausea (feeling of having an urge to vomit): 7 people, 21.88%

What are the existing conditions these people have? *

Oedema Peripheral (superficial swelling): 3 people, 9.38%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.25%
Prostate Cancer: 2 people, 6.25%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 6.25%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 2 people, 6.25%
White Blood Cell Count Decreased: 1 person, 3.12%
Heart Attack: 1 person, 3.12%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 3.12%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 1 person, 3.12%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Zide and have Hypoproteinaemia?

- Check whether Hypoproteinaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zide:

Zide (183,246 reports)

Browse all side effects of Zide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoproteinaemia:

Hypoproteinaemia (533 drugs)

Browse all the conditions that are associated with Hypoproteinaemia:

Hypoproteinaemia (563 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide (the active ingredients of Zide) and Zide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.